| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.2 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.2 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.2 |